Monogram Health vs Abridge
Side-by-side comparison of AI visibility scores, market position, and capabilities
Value-based, in-home care for CKD and ESRD patients; $542M raised; Humana partnership expanding across Southeast US.
About
Monogram Health delivers personalized in-home care for patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD), integrating nephrology, primary care, and chronic condition management in a value-based model. The company partners with leading health plans—including Humana and CVS/Aetna—to bring evidence-based, multidisciplinary care directly to patients' homes, improving access while reducing hospitalizations and overall medical costs.
Pittsburgh ambient clinical AI (founded by cardiologist) at $5.3B valuation Jun 2025; $800M total ($300M a16z/Khosla Series E) deployed at UPMC 12K clinicians, Mayo Clinic, Johns Hopkins competing with Nuance DAX for physician documentation.
About
Abridge is a Pittsburgh, Pennsylvania-based healthcare AI clinical documentation platform — backed with approximately $800 million in total funding including a $300 million Series E in June 2025 led by Andreessen Horowitz and Khosla Ventures at a $5.3 billion valuation, following a $250 million Series D just four months prior at a $2.8 billion valuation — providing physicians, nurses, and care teams at 150+ health systems with AI that automatically converts patient-clinician conversations into structured clinical notes, saving physicians an average of 3 hours daily and generating high-quality documentation from UPMC (scaling to 12,000 clinicians enterprise-wide), Mayo Clinic, Johns Hopkins, and Emory Healthcare. Abridge's AI is trained on a proprietary dataset of over 1.5 million medical encounters, delivering specialty-specific documentation through deep Epic EHR integration. Founded in 2018 by cardiologist Dr. Shiv Rao.
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.